é¦æ¸¯ã®é«åº¦ãªèªæ²»ãèªããä¸å½ã®ä¸å½äºå¶åº¦ããé¦æ¸¯å½å®¶å®å ¨æ³ãã«ãã£ã¦åæºããä¸å½æ¬åã¨é¦æ¸¯ã®éèå¸å ´ã«è¡æãæ³¢åãã¦ãããä¸å½é貨ã®äººæ°å ãæ¥è½ããæ¬åããã¼ãé¦æ¸¯ã«éé¿ãæ¬åæè³å®¶ã«ããé¦æ¸¯æ ªè²·ãã¯è¨é²çãªæ°´æºã«è¨ããã§ãããä»å¾ãé¦æ¸¯ããä¸ç¶å°ãã¨ãã¦ã欧米ã«è³æ¬ãæµåºããããã ã¨äººæ°å å®ãå éãã¦ä¸å½çµæ¸ãå±æ©ã«é¥ããªã¹ã¯ãé«ã¾ããæ¯æ°ã¨éèã®ä¸¡é¢ã§ä¸ççµæ¸ã¸ã®å½±é¿ã大ãããªãã28æ¥ã®
ãã¾ããç«å¦ã§ãã使ãããç åæ§ã®ææ¨ã§ããè´å½å²åã¯ãCFRï¼Case Fatality Ratioã¾ãã¯Riskï¼ã¨ãããã®ã§ããããã¯ç¢ºå®è¨ºæãã¤ããæ£è ã®ãã¡ããã®ææã«ãã£ã¦æ»ã«è³ãå²åã§ããåæ¯ã確å®è¨ºæãã¤ããæ£è ã ã¨ããã¨ããããã¤ã³ãã§ãã 確å®è¨ºæãããæ£è ã®æ°ã¯å®æ°ãææ¡ã§ããã®ã§ããã®ä¸ã§äº¡ããªã£ã人ãæ°ãã¦è´å½å²åãè¨ç®ãããé常ã«åãããããèãæ¹ã ã ãããã¾ã§ã«åãã£ã¦ããææçã®è´å½å²åï¼CFRï¼ã¯ãSARSã10ãã¼ã»ã³ããMERSã35ãã¼ã»ã³ããã¹ãã¤ã³ããã3ãã¼ã»ã³ããã¢ã¸ã¢ããã0.5ãã¼ã»ã³ãã¨è¨ããã¦ãã¾ããããã¦ãããã¾ã§ã®ã¨ããCOVID-19ã¯ã1ãã¼ã»ã³ããã10ãã¼ã»ã³ãã¨ãããµãã«å¹ ãããã¾ããããã¯ãå½ã«ãã£ã¦ãæ¤æ»ä½å¶ãå»çä½å¶ãããã«ã¯ãææè ã®å¹´é½¢åå¸ãéãããã ã¨èãããã¾ãã è´å½å²åã¯ããã®ææçã®ç åæ§ã示ãã¨ã¦
ãCOVID-19ã®IFRãæ©ãæç¹ã§æ¨å®ããã®ã¯ããã¯ã西浦ãããã¡ã®ã°ã«ã¼ãã§ãããã¯2æ4æ¥ã®æç¹ã§è«æï¼â»4ï¼ã«ãªã£ã¦ãã¾ããæ¦æ¼¢ãããã£ã¼ã¿ã¼ä¾¿ã§æ¥æ¬ã«å¸°å½ãã565åã®æ¥æ¬äººãå ¨å¡PCRæ¤æ»ãåãããã¨ããææ確èªçãæ±ãã¦ãæ¦æ¼¢ã«ãããç¡çåæ§ææè ãå«ããææè ã®ç·æ°ãæ¨å®ããä¸ã§ãææè´å½å²åï¼IFRï¼ã¯0.3ï½0.6ãã¼ã»ã³ãã ã¨çµè«ãã¾ãããããã¯ä»ã®ç 究ã°ã«ã¼ãã§ãå¥ã®ãã¼ã¿ã§æ°åãåºãã¦ã西浦ãããã¡ãããããé«ãå¤ãå ±åãã¦ãã¾ãããæ¡ã¯åãã§ãã ãã®ããã«ãã¦è´å½å²åã«ã¯ãCFRã¨IFRã¨ããäºç¨®é¡ããã£ã¦ããããã®æ§è³ªä¸ãæ¡ãéããã¨ãæèãã¦ãããªããã°ãªããªããããã»ã©è§£èª¬ãã¦ããã£ããå£ç¯æ§ã¤ã³ãã«ã¨ã³ã¶ã®é¢é£æ»ããããã¯å»çæ°´æºãä½ãå½ã ã®ç¶æ ãèæ ®ããããæ¡å¤§çã®è´å½å²åããã©ãæ±ããã¨ããåé¡ã¨ãããã¦ãé常ã«ããããããæ··ä¹±ããããããSNS
æ¨æè±ããã®ãåãåããã人éæ§ã ãªã¢ãªãã£ã·ã§ã¼ã¨ãã¦è©å¤ã®é«ãã£ãããã©ã¹ãã¦ã¹ãã§ãããç§ããããã°ãããã¡ãã¨è¦³ã¦ããªãã¦ããã¾åãåã£ã¦ããèªåã®äººçããªã¢ã«ããã¦æéããªãã£ããã ã¨è¨ã訳ãã¤ã¤ãã亡ããªãããã¨èãã¦è¦³ç´ããããã¦ããã¾ããã ããããå½ããåã«ä½¿ãããããã«ãªã£ã¦ãçªçµã¨ããã(SNS)ã¨ãè¦è´è ã«ãã£ã¦èªç±ã«è¡ãæ¥ã§ããç¶æ³ã«ãªãã¨ããã種ããã¬ãã®ä¸ã®ãæ åä½åä¸ã®æ¼åºããããã®ã¾ã¾æ¬äººã®è©å¤ããã©ã³ãã£ã³ã°ã«ç´çµãã¦ãã¾ãã ãããæ¬äººã«å¯¾ãã誹è¬ä¸å·ã§ã¯åã¾ããªããé常ã«å¼·ãããã·ã³ã°ã«ç¹ãã£ã¦ãã£ã¦ãã¾ãã®ã¯å¾ã ã«ãã¦ããã¾ãã ãã¬ãçªçµåºæ¼è ã®æ¹ã®æ¬å½ã®äººæ ¼ãªã©åããã¯ãããªãã®ã«ããã¬ãçªçµãé¢ç½ãããããã«è¡ã£ãç·¨éãæ¼åºã§ãããããã®äººã®æ¬æ§ã ã¨è¦è´è ã¯æãè¾¼ãã§ãã¾ããæ°ã«å ¥ããªãã¨ããã·ã³ã°ãã¦å½ç¶ãã¨ãªã£ã¦ãã¾ãã çªçµã®ä¸ããã
å®åé¦ç¸ã¯ã5æ25æ¥ã«ç·æ¥äºæ 宣è¨ãå ¨é¢è§£é¤ãã¾ããã49æ¥éã«ãããç°å¸¸äºæ ãããã£ã¨çµäºãããã¨ã«ãªã£ãã®ã§ãã ãã®æªç½®ã¯ãå½åã®4æ7æ¥ã«7é½åºçã ã£ããã®ããææè ã®æ¥å¢ãåãã¦4æ16æ¥ã«å ¨é½éåºçã«ã¾ã§æ¡å¤§ãã¾ãããã®å¾ã¯ãç¶æ³ãæ¹åããå°åããå¾ã ã«è§£é¤ããã5æ25æ¥ãæå¾ã®æ¥ã¨ãªãã¾ãããé¨ããä¸æ®µè½ããã®ã§ãããã§ä¸æ¯ä»ãããã§ãã ã§ã¯ããªãææãåæããã®ã§ããããããã¼ã¿ã丹念ã«èª¿ã¹ã¦ããéç¨ã§ãèå³æ·±ãäºå®ã次ã ã¨æµ®ãã³ä¸ãã£ã¦ãã¾ãããããã§ã¯ãç§èªèº«ã®åå¿é²ã¨ãã¦ãä»ã¾ã§ã«çºè¦ããå 容ãæ¸ãçãã¦ãããã¨ã«ãã¾ãã å ¨ä½åã®æ´ç 大ã¾ãã«çµç·¯ãæ´çãã¦ã¿ã¾ãããã 1æãã2æã«ããã¦ãä¸å½ã»æ¦æ¼¢ãã第1æ³¢ã襲æ¥ãã3ææ«ã¾ã§ã«åæ ãã®å¾ã®3æã«æ¬§ç±³ã§ææãççºãããã®ä½æ³¢ã§æ¥æ¬ã«ç¬¬2æ³¢ãè¥²æ¥ 3æã«2,000ï½3,000人ã®ç¡çç¶è ããã¼ãã§ãã¯ã§å ¥
æ°åã³ããã¦ã¤ã«ã¹ã«å¯¾ããæä½ãä½ãã¯ã¯ãã³éçºã¯ä¸æ¯ã ã¨æãã¾ããã¨ããã®ããä¸å½ã®åæã®ç 究ã«ããã¨ãå復ããæ£è ã®ä¸ã«ã¯æä½ãæã£ã¦ããªã人ãããããã§ããç¡çç¶ã®æ£è ã¾ã§å«ããã¨ãæä½ãæããªã人ã®æ°ãå復ããæ£è ã®å¤§åãå ãããã¨ã«ãªãã§ãããã æ¥æ¬ã§å®æ½ãããä¿¡é ¼ã§ããæä½æ¤æ»ã®çµæã¯ãé½æ§çãæ±äº¬é½ã§0.6ï¼ ãæ±åå°æ¹ã§0.4ï¼ ã«ã¨ã©ã¾ãã¾ãããæ±äº¬ã®0.6ï¼ ã¯PCRæ¤æ»æ£è ã®10åãæ±åå°æ¹ã®0.4ï¼ ã¯PCRæ¤æ»æ£è ã®100åã§ãããããã¯ä½ãæå³ããã®ã§ããããï¼ ç§ãã¡ãPCRæ¤æ»ã§è¿½è·¡ã§ãããããã¯ããã«å¤ãã®ææè ãåå¨ãã¦ãããåããã¨ãã©ãã®å½ã«ã¤ãã¦ãè¨ãã æä½ã®ç£ççã¯å°åã«ãã£ã¦10åç°ãªããæ±åã®PCRæ¤æ»ã®å®æ½æ°ã¯æ±äº¬ã®10åã®1 ã¾ããæä½æ¤æ»ã§ã¯ãã®ç æ°ã®å ¨ä½åã¯ã¤ãããªãã¨ããã®ãå¯ä¸ã®ãã¤ã³ãã§ãã ã¨ããã³ã¹ã¯ããã¾ãããç§èªèº«ã®çµé¨ãè
ãè¶ éæ»äº¡ã°ã©ãæ¹ç«ãçæã«ãå½ç«ææç ã¯èª å®ã«çããï¼ ä¸å¯è§£ãªã°ã©ãã®å¤åãæ¤è¨¼ãããããå½ç«ææç ã¯åæ°åãªã©ã®ãã¼ã¿ãå ¬éãã ä½è¤ç« ãã¸ã£ã¼ããªã¹ããå ææ¥æ°èè¨è ãäºææ¸æ¿æ°ç¤¾ç·¨éå§å¡ä¼å§å¡é· å®åæ¿æ¨©ä¸ã§ã¯é²éª¨ãªå ¬ææ¸æ¹ç«ãè¡ãããçµ±è¨æä½ãªã©ãç¹°ãè¿ãããããã®ãããè¡æ¿ä¸ã®å¤å°ã®ãã¹ã§ã¯é©ããªããªã£ã¦ããããã³ããã¦ã¤ã«ã¹å¯¾çã§æ³¨ç®ããã¦ãããè¶ éæ»äº¡ãçµ±è¨ã®ãå¤äºãã«ã¯å¿åºé©ããããã ç§ããå¤äºãã«æ°ã¥ããã®ã¯ã5æ20æ¥å ¬éã®ä½è¤ç« ãã¼ãããææè æ°ããããè¶ éæ»äº¡ãã«æ³¨ç®ããï¼ï½æ±äº¬ã¯ï¼é±éã§ï¼ï¼ï¼äººããç´¹ä»ãããã¤ãã¿ã¼ã«å¯¾ãããã©ãã¯ã¼ã®æ¹ãã5æ24æ¥ã«ãå½ç«ææç ãå ¬è¡¨ããè¶ éæ»äº¡ã®ã°ã©ããå¤æ´ããã¦ãããæ¹ç«ã§ã¯ãªãããã¨ã®ææããã£ãããã ã ãã®ãæ¹ç«ãçæã¨ã¯ââãã¾ãã¯ãå½ç«ææçç 究æãå ¬è¡¨ããäºã¤ã®ãè¶ éæ»äº¡ãçµ±è¨ã°ã©ããã覧ããã ãããã
ãå½å å¤ã®ã¡ãã£ã¢ã§åºãå ±éããã¦ããæ°åã³ããã¦ã¤ã«ã¹ææç(COVID-19)ã®ææè æ°ã¯æ¬å½ã®ææè æ°ããããã£ã¨å°ãªãå¯è½æ§ãé«ããã¨ãã²ãªã«ã¯ã»ã¢ã¦ã°ã¹ã大å¦ã²ããã£ã³ã²ã³ç¾ä»£ã¤ã³ãç 究ã»ã³ã¿ã¼æé·ãåããã»ãã¹ãã£ã³ã»ãã©ã«ãã¼ææãææããå®éã¯ä¸çä¸ã®ææè æ°ãæ°åä¸äººã¨ããã¬ãã«ã«éãã¦ããå¯è½æ§ã示åãã¦ãã¾ãã Presseinformationen - Georg-August-Universität Göttingen http://www.uni-goettingen.de/de/3240.html?id=5855 COVID-19: On average, only 6% of actual infections detected worldwide https://medicalxpress.com/news/2020-04-covid-average-ac
é¦æ¸¯ã«é§çããä¸å½è»ã®å¸ä»¤å®ã¯ãå½ä¼ã«ãããå ¨äººä»£ã§å¯©è°ä¸ã®å½å®¶å®å ¨æ³å¶åº¦ããåè£å¢åãéãä¸ãããããã¨è¿°ã¹ãé¦æ¸¯ã§ã®æè°æ´»åãç½å¶ï¼ããããï¼ãã¾ããã é¦æ¸¯ã«é§çããä¸å½äººæ°è§£æ¾è»ã®é³é祥å¸ä»¤å®ã¯ä¸å½ã¡ãã£ã¢ã®åæã«å¯¾ããå½å®¶å®å ¨æ³å¶åº¦ãé¦æ¸¯ã«å°å ¥ãããã°ãåè£å¢åãå¤é¨ã®å¹²æ¸å¢åãéãä¸ããããã ãããã¨ä¸»å¼µãã¾ããããã®ããã§ããé§çããå°æ ¡ã¨å µå£«ã¯ä¸å¤®æ¿åºã®æ±ºå®ãæåºã¨ãã¦å®è¡ããæ³ã«å¾ã£ã¦ä»»åãéè¡ãããã¨å¼·èª¿ããä»å¾ã¯ä¸å½è»ãç´æ¥ãé¦æ¸¯ã®æ²»å®ç¶æã«é¢ä¸ããå¯è½æ§ã示åãã¾ãããé¦æ¸¯ã§ã¯æ³å¶åº¦ã®å°å ¥ã«å対ããæè°æ´»åãé£æ¥è¡ãããã¢ã¡ãªã«ãã¯ãããã¤ã®ãªã¹ããªã¼ã¹ãã©ãªã¢ãªã©åå½ãããæ¸å¿µã®å£°ãç¸æ¬¡ãã§ãã¾ãã
ãªã³ã¯éç®æ¬¡ å½å å¤ã®ç¶æ³ æ¿åºæ©é¢ã»å½éæ©é¢ç å¦è¡æ å ± ç«å¦è«æ ååçç©å¦ï¼ã¦ã¤ã«ã¹å¦è«æ è¨åºè«æ ã¤ã³ãã©ãããã¯é¢ä¿ ã¯ã¯ãã³é¢ä¿ å¤ç°æ ªé¢ä¿ æç³»åã¡ã¢ç®æ¬¡ æ°åã³ããã¦ã¤ã«ã¹ï¼2020å¹´1æ6æ¥ï¼11æ¥ï¼ ã¤ã³ããªã°ã«ã¼ãã«ããæ£è æ°æ¨å®ï¼2020å¹´1æ18æ¥ï¼ æ£è æ°æ¥å¢ï¼è¥¿æµ¦ãããã¡ã®è«æï¼2020å¹´1æ20æ¥ï¼23æ¥ï¼ WHOã¯PHEIC宣è¨ããï¼2020å¹´1æ23-24æ¥ï¼ 絶対ãªã¹ã¯ã¨ç¸å¯¾ãªã¹ã¯ï¼2020å¹´1æ26æ¥ï¼ ç 究ã©ãã·ã¥ãèµ·ããããï¼2020å¹´1æ27æ¥ï¼ ãªãæ°ææçã§ãªãæå®ææçãªã®ãï¼ããªãåå´ç令ã§ãªãé£è°æ±ºå®ãªã®ãï¼ï¼2020å¹´1æ27æ¥ï¼ ã³ããã¦ã¤ã«ã¹ã«å¯¾ããå人é²å¾¡ï¼2020å¹´1æ27æ¥ï¼ å½å ããï¼ããææçºçï¼2020å¹´1æ28æ¥ï¼ ãã©ãã¼ã¢ããã»ã³ã¿ã¼è¨ç½®ï¼ç·æ¥é¿é£çï¼2020å¹´1æ29æ¥ï¼ PHEICã®å®£è¨ï¼2020å¹´1æ3
Notice You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader. All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY li
äºé²æ¥ç¨®ã®æ¬ (raison d'êtreãã®ããµã¤ããã¼ã) ç°¡åæ¯æãã·ã£ã³ãã¼ (人æ°ååå£ã³ãã©ã³ãã³ã°) ãããã飲ãã§è¡ç³å¤å¯¾ç (ãã ãã京æ¹è¶) ã®ã©ã³ãã¬ã¼çå群 çç¶ãæ°ã«ãªã£ãã®ã§èª¿ã¹ã¦ã¿ã¾ãã (話é¡ã®ãã¼ã¯ã¼ãã§æ å ±åé) âãã¤ã³ãUPéå¬ä¸â (è±ã®ãã館ã®ããã°) ãã¡ãè飾åºäºæå ¬ååæ´¾åºæ 171 (ãã³ã¬æ å ±ãµã¤ã) åã³çªçµéæ¿ï¼å®®å´å®£åã¢ãã®æ¾éäºæ åç»ï¼ (åã³çªçµéæ¿ï¼å®®å´å®£åã¢ãã®æ¾éäºæ åç»ï¼) ãå®ãããçç±ã¯ä¸æï¼ç¬ï¼ã ãã©ãã£ããå®ãã®çºè¦ (ãå°ãã¸ã大ç»é¢ãã¬ãéæã®ã¿ï¼ã¾ã¡ãã£ã¦ãããããï¼ãç¥ãã) æ¤è¨¼ï¼ããã¯ã¯ãã³å ±éã¯ä½ã ã£ããã ãã (æ±äº¬æ¥åï¼ å å¤åå»ã®æ¥ã ) ã¡ãã£ã¢ã®ç½ªï¼ï¼å¸¸æ åããããã·ã³ã°å ±éã§ã¯å»çã¯æ¹åããªã (æ±äº¬æ¥åï¼ å å¤åå»ã®æ¥ã ) ã¨ãã³ã»ã®ã»ãã¯ã®ï½¢ææçç«å¦ãï¼æåå ï¼ãèªã¿ã¾ãããè²·ã£ã¦ç½®ã
","naka5":"<!-- BFF501 PCè¨äºä¸ï¼ä¸â¤ä¼ç»ï¼ãã¼ãï¼1541 -->","naka6":"<!-- BFF486 PCè¨äºä¸ï¼ä¸â¥ãã¸ç·¨ï¼ãã¼ãï¼8826 --><!-- /news/esi/ichikiji/c6/default.htm -->","naka6Sp":"<!-- BFF3053 SPè¨äºä¸ï¼ä¸â¥ãã¸ç·¨ï¼ãã¼ãï¼8826 -->","adcreative72":"<!-- BFF920 åºåæ ï¼ADCREATIVE-72 ãããªç¹éã -->\n<!-- Ad BGN -->\n<!-- dfptag ï¼°ï¼£èªå°æ ï¼è¡ â ãããã -->\n<div class=\"p_infeed_list_wrapper\" id=\"p_infeed_list1\">\n <div class=\"p_infeed_list\">\n <div class=\"
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}